Nine Point Two Capital LLC Intellia Therapeutics, Inc. Transaction History
Nine Point Two Capital LLC
- $252 Million
- Q4 2023
A detailed history of Nine Point Two Capital LLC transactions in Intellia Therapeutics, Inc. stock. As of the latest transaction made, Nine Point Two Capital LLC holds 12,147 shares of NTLA stock, worth $122,563. This represents 0.15% of its overall portfolio holdings.
Number of Shares
12,147Holding current value
$122,563% of portfolio
0.15%Shares
2 transactions
Others Institutions Holding NTLA
# of Institutions
336Shares Held
96.1MCall Options Held
1.06MPut Options Held
863K-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl12.5MShares$126 Million1.28% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.2MShares$103 Million0.0% of portfolio
-
Black Rock Inc. New York, NY9.6MShares$96.8 Million0.0% of portfolio
-
State Street Corp Boston, MA5.21MShares$52.5 Million0.0% of portfolio
-
Morgan Stanley New York, NY3.81MShares$38.5 Million0.0% of portfolio
About Intellia Therapeutics, Inc.
- Ticker NTLA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,011,800
- Market Cap $767M
- Description
- Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...